Evidence map›Paper›PMID 41239307›Full record

ArticleBMC infectious diseases2025

Machine learning to examine adequate awareness and positive perception of HIV pre-exposure prophylaxis among women in sub-Saharan Africa: evidence from 2021-2024 surveys.

Bewuketu Terefe, Abraham Keffale Mengistu, Andualem Enyew Gedefaw, Eliyas Addisu Taye, Fentahun Bikale Kebede, Jamilu Sani, Nebebe Demis Baykemagn, Tirualem Zeleke Yehuala, Amanuel Worku

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bewuketu TerefeSchool of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. woldeabwomariam@gmail.com.ORCID http://orcid.org/0000-0002-0063-0999
Abraham Keffale MengistuDepartment of Health Informatics, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Andualem Enyew GedefawDepartment Health Informatics, Institute of Public Health and College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Eliyas Addisu TayeDepartment Health Informatics, Institute of Public Health and College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Fentahun Bikale KebedeStrategic Affairs Executive Office, Ministry of Health, Addis Ababa, Ethiopia.
Jamilu SaniDepartment of Demography and Social Statistics, Federal University Birnin Kebbi, Birnin Kebbi, Nigeria.
Nebebe Demis BaykemagnDepartment Health Informatics, Institute of Public Health and College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Tirualem Zeleke YehualaDepartment Health Informatics, Institute of Public Health and College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Amanuel WorkuSchool of Information Science, Addis Ababa University, Addis Ababa, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the proven efficacy of HIV pre-exposure prophylaxis (PrEP), adequate awareness and positive perception among women in sub-Saharan Africa (SSA) remain poorly understood, limiting uptake. Existing studies are largely country-specific, focus on limited socio-demographic factors, and rarely leverage advanced analytical methods to identify key determinants. This study addresses these gaps by applying machine learning to population-based surveys across multiple SSA countries.

methodsWe analyzed nationally representative surveys from eight SSA countries conducted between 2021 and 2024, including 123,132 HIV negative women aged 15–49 years. Primary outcomes were adequate awareness and positive perception of PrEP. Predictor variables included socio-demographic characteristics, behavioral factors, healthcare utilization, and contextual features. Data preprocessing included multiple imputation, one-hot encoding, and min–max scaling. Recursive feature elimination and correlation analysis guided feature selection. Five machine learning models—KNN, XGBoost, CatBoost, LightGBM, and Gradient Boosting—were trained and evaluated using accuracy, precision, recall, F1-score, and ROC AUC. SHAP values provided interpretable insights.

resultsOnly 14.9% of women demonstrated adequate awareness and positive perception of PrEP, with marked variation across countries (5.6% in Tanzania to 73.6% in Lesotho). Younger age (15–24 years), lower education, limited media exposure, and minimal healthcare engagement were strongly associated with inadequate awareness. CatBoost outperformed other models (accuracy 0.91, F1-score 0.88), followed by XGBoost (accuracy 0.89, F1-score 0.86). SHAP analysis confirmed age, education, media exposure, healthcare visits, and marital status as the most influential predictors.

conclusionAdequate awareness and positive perception of PrEP among women in SSA remains inadequate and unevenly distributed, highlighting urgent gaps in education and outreach. Machine learning effectively identifies key drivers, enabling targeted interventions to improve PrEP uptake across diverse socio-demographic contexts. These findings can inform country-specific PrEP awareness campaigns and policy strategies to enhance HIV prevention efforts. CLINICAL TRIAL: Not applicable.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsMachine LearningPre-Exposure ProphylaxisAdolescentAdultAfrica South of the SaharaBoosting Machine Learning AlgorithmsFemaleHumansMiddle AgedSub-Saharan African PeopleSurveys and QuestionnairesYoung AdultHIV pre-exposure prophylaxisMachine learningPopulation-based surveysPrEP adequate awareness and positive perceptionSub-Saharan AfricaWomen’s health

Identifiers

PMID41239307
PMCPMC12619335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.